Fundraising FoxSolgate GmbH
Klosterneuburg, AT · Founded 2020 · 1 known investors
Find your way into Solgate GmbH
Solgate is a drug discovery company developing small-molecule drugs that target solute carrier (SLC) membrane transporter proteins, using a platform combining chemical, biological, and computational technologies. A spin-off from CeMM/ÖAW and IST Austria, it focuses on advancing a pipeline of SLC-targeting compounds toward clinical development for human disease.
Founders & leadership
Solgate GmbH was founded in 2020 by Ariel Bensimon, PhD, Stefan Kubicek, PhD, Gaia Novarino, PhD, Giulio Superti-Furga, PhD, and Georg Winter, PhD.
AB
Ariel Bensimon, PhDCo-Founder & Chief Executive Officer
SK
Stefan Kubicek, PhDCo-Founder
GN
Gaia Novarino, PhDCo-Founder
GS
Giulio Superti-Furga, PhDCo-Founder
GW
Georg Winter, PhDCo-Founder
Investors · 1
Frequently asked questions
- What does Solgate GmbH do?
- Solgate is a drug discovery company developing small-molecule drugs that target solute carrier (SLC) membrane transporter proteins, using a platform combining chemical, biological, and computational technologies. A spin-off from CeMM/ÖAW and IST Austria, it focuses on advancing a pipeline of SLC-targeting compounds toward clinical development for human disease.
- Who founded Solgate GmbH?
- Solgate GmbH was founded by Ariel Bensimon, PhD, Stefan Kubicek, PhD, Gaia Novarino, PhD, Giulio Superti-Furga, PhD, Georg Winter, PhD in 2020.
- Who are Solgate GmbH's investors?
- Solgate GmbH's investors include Wlanholding.
- Where is Solgate GmbH headquartered?
- Solgate GmbH is headquartered in Klosterneuburg, AT.